FDA (Drugs) recall action 65422
The FDA (Drugs) publishes a recall like this one as 4 separate product records. They share a firm, a date and a cause; this page is all of them in one place, so the scale of the action is visible rather than spread across 4 pages.
Defective container: products are packaged in pouches which may not have been fully sealed
The agency’s own wording, quoted from the enforcement report.
The unit total adds up the quantities the agency stated for each product. Where a product record gave no figure, or gave a weight rather than a count, it contributes nothing — so the real total is at least this, never less.
Novartis Consumer Health is recalling No Doz Max Strength caplets because the pouches may not be fully sealed.
Novartis is recalling 472,000 pouches of Parsel Plus in Brazil and Panama because the packaging may not be fully sealed.
Novartis is recalling 10.6 million Excedrin Migraine pouches because the packaging may not be fully sealed, potentially compromising product integrity.
Novartis is recalling Excedrin Extra Strength tablets in pouches that may not be fully sealed. The recall covers products distributed in the US, Puerto Rico, Brazil, and Panama.